Assessment of the use of synthetic data to support the generation of real-world evidence in cancer in England

被引：0
|
作者：
Abbasi, Ali [1 ,2 ]
Hermans, Ruben [1 ]
Grimson, Fiona [1 ]
Kim, Joseph [1 ,3 ]
Bray, Benjamin [1 ,4 ]
Layton, Deborah [1 ,5 ]
Reich, Adam [1 ]
机构：
[1] IQVIA, London, England
[2] Univ Med Ctr Groningen, Groningen, Netherlands
[3] London Sch Hyg & Trop Med, London, England
[4] Kings Coll London, London, England
[5] Univ Keele, Newcastle Upon Tyne, Tyne & Wear, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
226
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [21] SynthDa: Exploiting Existing Real-World Data for Usable and Accessible Synthetic Data Generation
    Rajendran, Megani
    Tan, Chek Tien
    Atmosukarto, Indriyati
    Grant, Andrew
    Ng, Aik Beng
    Zhou, Zhihua
    See, Simon
    PROCEEDINGS SIGGRAPH ASIA 2023 TECHNICAL COMMUNICATIONS, SA TECHNICAL COMMUNICATIONS 2023, 2023,
  • [22] Use of Real-World Evidence to Support FDA Approval of Oncology Drugs
    Feinberg, Bruce A.
    Gajra, Ajeet
    Zettler, Marjorie E.
    Phillips, Todd D.
    Phillips, Eli G., Jr.
    Kish, Jonathan K.
    VALUE IN HEALTH, 2020, 23 (10) : 1358 - 1365
  • [23] Editorial: Real-world data and real-world evidence in hematologic malignancies
    Malagola, Michele
    Ohgami, Robert
    Greco, Raffaella
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] When can real-world data generate real-world evidence?
    Rahman, Motiur
    Dal Pan, Gerald
    Stein, Peter
    Levenson, Mark
    Kraus, Stefanie
    Chakravarty, Aloka
    Rivera, Donna R.
    Forshee, Richard
    Concato, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [25] Rapid use of real-world data in safety signal assessment
    McDermott, Rachel
    Patadia, Vaishali
    von Klot, Stephanie
    Asubonteng, Julius
    Miller, Mary K.
    Golchin, Negar
    Manlik, Katrin
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 496 - 497
  • [26] Real-world evidence use in assessments of cancer drugs by NICE
    Bullement, Ash
    Podkonjak, Tanja
    Robinson, Mark J.
    Benson, Eugene
    Selby, Ross
    Hatswell, Anthony J.
    Shields, Gemma E.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (04) : 388 - 394
  • [27] PMDA Perspective on Use of Real-World Data and Real-World Evidence as an External Control: Recent Examples and Considerations
    Asano, Junichi
    Sugano, Hiromi
    Murakami, Hiroyuki
    Noguchi, Atsushi
    Ando, Yuki
    Uyama, Yoshiaki
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025,
  • [28] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Richard E. Gliklich
    Michelle B. Leavy
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 303 - 307
  • [29] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Gliklich, Richard E.
    Leavy, Michelle B.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 303 - 307
  • [30] REAL-WORLD DATA AND REAL-WORLD EVIDENCE TERMINOLOGY HARMONIZATION: EVIDENCE GAPS AND FUTURE STEPS
    Chhaya, V
    Kumar, S.
    Khambholja, K.
    VALUE IN HEALTH, 2023, 26 (12) : S524 - S525
12345